Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles W Carroll

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
The Journal of Pathology|February 2, 2022
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytesSandra Gray-Rodriguez, Melanie P Jensen, Maria Otero-Jimenez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Pathology|February 2, 2022
Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytesSandra Gray-Rodriguez, Melanie P Jensen, Maria Otero-Jimenez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Ebola Virus Persistence in Breast Milk After No Reported Illness: A Likely Source of Virus Transmission From Mother to ChildDaouda Sissoko, Mory Keïta, Boubacar Diallo, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Nature Communications|August 23, 2020
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interactionMonir Ejemel, Qi Li, Shurong Hou, et al.
Genome Biology|January 20, 2017
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virusXuan Liu, Emily Speranza, César Muñoz-Fontela, et al.
Vaccine|July 13, 2021
One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge modelKaren E Gooch, Trevor R F Smith, Francisco J Salguero, et al.
Msphere|September 2, 2017
Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the GutMiles W Carroll, Sam Haldenby, Natasha Y Rickett, et al.
Ebiomedicine|December 6, 2020
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret modelPamela C Proud, Daphne Tsitoura, Robert J Watson, et al.
Msphere|July 21, 2021
Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERSWaleed Aljabr, Muhannad Alruwaili, Rebekah Penrice-Randal, et al.
Lancet (London, England)|August 8, 2015
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trialAna Maria Henao-Restrepo, Ira M Longini, Matthias Egger, et al.
Pageof 15